What is Prime Medicine's cash ratio?

Prime Medicine (PRME) reported cash ratio of 2.1× in Q1 2026.

How has Prime Medicine's cash ratio changed year-over-year?

Prime Medicine's cash ratio decreased by 30.6% year-over-year, from 3.1× to 2.1×.

What is the long-term trend for Prime Medicine's cash ratio?

Over 4 years (2021 to 2025), Prime Medicine's cash ratio has grown at a -12.1% compound annual growth rate (CAGR), from 3.4× to 2×.

What does cash ratio mean?

Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.

Prime Medicine PRME Cash ratio

Cash ratio at other companies

Eli LillyLLY

0.1×0.0×

Vertex PharmaceuticalsVRTX

1.4×+0.2×

Intellia TherapeuticsNTLA

1.8×+0.6×

CRISPR TherapeuticsCRSP

3.1×+1.1×

Beam TherapeuticsBEAM

3.9×+0.1×

RegenxbioRGNX

0.2×-1.0×

Other financials

Income statement

See full

Revenue$838.0K-61.6%

Operating income-$50.7M+3.3%

Net income-$49.1M+5.3%

EPS (diluted)-$0.28+30.0%

Balance sheet

See full

Cash & equivalents$77.8M-26.6%

Total debt$114.5M-5.5%

Total equity$76.7M-28.3%

Total assets$294.7M-10.2%

Cash flow

See full

Operating cash flow-$42.7M+12.6%

CapEx$214.0K-91.2%

Free cash flow-$42.9M+16.3%

Valuation

See full

Market cap$574.36M+111%

Enterprise value$611.08M+113%

P/S124×+6.3×

Profitability

See full

Operating margin-4,498.1%-1,134pp

Net margin-4,342.4%-1,099pp

FCF margin-3,607.4%—

Returns & leverage

See full

Return on equity-216.1%+1,519pp

Debt / equity1.5×+0.4×

Current ratio3.8×-1.0×

Where this comes from

Calculated from Prime Medicine’s reported figures.

cash and equivalents/total current liabilities=2.1×

Based on the most recent quarter.

The official record: Prime Medicine’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prime Medicine's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Prime Medicine's cash ratio?: Prime Medicine (PRME) reported cash ratio of 2.1× in Q1 2026.
How has Prime Medicine's cash ratio changed year-over-year?: Prime Medicine's cash ratio decreased by 30.6% year-over-year, from 3.1× to 2.1×.
What is the long-term trend for Prime Medicine's cash ratio?: Over 4 years (2021 to 2025), Prime Medicine's cash ratio has grown at a -12.1% compound annual growth rate (CAGR), from 3.4× to 2×.
What does cash ratio mean?: Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.